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Abstract 
  
 Cerebral Aneurysms (CAs) are characterized by a pathological wall structure with internal 
elastic lamina and media disruption which leads to focal weakened pouches of the arterial wall. 
The prevalence of unruptured CAs is estimated to be 2-5% in the general population. During the 
past few decades, the pathophysiological mechanisms behind the formation, growth and rupture 
of CAs have been the focus of numerous research studies. In this review, the inflammatory 
pathways, genetics and risk factors for the formation, growth and rupture of CAs are summarized. 
In addition, the concepts of geometrical indices, flow patterns and fluid dynamics that govern CA 
development are discussed. 
 
Keywords: cerebral aneurysms; intracranial aneurysms; inflammation; wall shear stress; flow 
dynamics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
The prevalence of unruptured cerebral aneurysms (CA) is estimated to be 2-5% in the 
general population.1 CAs are characterized by a pathological wall structure with internal elastic 
lamina and media disruption which leads to focal weakened pouches of the arterial wall.2,3 The 
majority of CAs remain clinically silent during the lifetime of patients who harbor them. However, 
aneurysmal rupture and subsequent subarachnoid hemorrhage (SAH), the most catastrophic 
sequelae, are associated with an approximately 50% mortality and 30-50% neurologic morbidity 
rate among the survivors.4 Despite the technological advances and use of novel devices to manage 
CAs, they continue to pose a significant risk of mortality and neurologic morbidity.4 
During the past few decades, the pathophysiological mechanisms behind the formation, 
growth and rupture of CAs have been the focus of numerous research studies.5,6 Inflammatory 
pathways and mediators implicated in CA formation and growth along with extensive imaging 
studies have provided new insights into our understanding of CAs.7,8 Deciphering the biology and 
physics of CAs could potentially optimize patient management and result in novel treatment 
options. This review aims to summarize current scientific knowledge with regards to CA 
formation, growth and rupture. 
 
Biology of CAs 
I) Inflammatory Pathways  
 Several studies have demonstrated that inflammation has an impact on the formation and 
growth of CAs.8–11 One hypothesis is that an initial hemodynamic insult leads to complex 
inflammatory processes which involve the matrix metalloproteinases (MMPs), vascular smooth 
muscle cells (VSMCs), macrophages and oxidative stress. 
 Endothelial dysfunction is considered the first step in the formation of CAs and this can be 
the result of smoking, hypertension, local flow dynamics dysregulation and non-modifiable factors 
including genetics. Oxidative stress is considered to be a major source of endothelial injury and 
entails the accumulation of free radicals due to increased production and/or decreased removal.5 
The next step involves a coordinated inflammatory response implicating macrophages, mast cells, 
T cells and a number of cytokines and inflammatory mediators. This inflammatory response leads 
to the phenotypic modulation of VSMCs, which are the main matrix-synthesizing cells within the 
media of the arterial wall.12 These VSMCs induce disruption of the internal elastic lamina, cause 
dysregulated collagen synthesis and extracellular matrix remodeling.13 The late steps in the biology 
of CA growth involve VSMC apoptosis which results in further thinning of the media and 
increased rupture risk.11 
 In addition, macrophages infiltrate the vascular wall as a result of the inflammatory 
mediators and cytokines. Macrophages express and release MMPs which cleave the extracellular 
matrix and collagen of the arterial wall.7 This, in turn, leads to the recruitment of other 
inflammatory cells, upregulates the expression of additional proteases and rapidly increases the 
degeneration and weakening of the arterial wall.14 These processes are often characterized by a 
positive feedback regulation and act together, ultimately culminating in aneurysm formation and 
growth. Further inflammation may severely impact the arterial wall and trigger aneurysmal rupture 
and SAH.11  
 Several experimental studies have supported these inflammatory pathways. A number of 
studies have focused on the VSMCs’ and macrophages’ role in the biology of CAs. The study by 
Ali et al. suggested that tumor necrosis factor- alpha (TNF-alpha) is implicated in the phenotypic 
modulation of VSMCs towards a pro-inflammatory and matrix remodeling phenotype.13 Guo et 
al. showed that the density of VSMCs in the media of CAs was significantly lower compared to 
normal arterial walls (43.9 VSMC/HPF vs. 222.8 VSMCs/HPF; p<0.01).15 Interestingly, a study 
of mice with elastase-induced CAs showed that macrophages were the predominant cells that 
infiltrated the aneurysm wall. 16 They also demonstrated that mice with macrophage depletion had 
a statistically significant lower incidence of CAs when compared with the control group (p<0.05). 
In addition, this study supported that monocyte chemotactic protein-1 (MCP-1) depleted mice also 
had a statistically significant lower incidence of CAs when compared with wild-type mice 
(p<0.05).16 Aoki et al. suggested that MCP-1 plays a critical role in CA formation; conversely, 
they demonstrated that its inhibition resulted in the cessation of CA growth in mice.17   
Oxidative stress and reactive oxygen species were shown to induce VSMC phenotypic 
switching and apoptosis; this was postulated to play a role in CA formation growth and risk of 
rupture.18–20 A study of both human and mice intracranial aneurysms demonstrated that inducible 
nitric oxide synthase (iNOS) immunoreactivity was consistent with the development of early 
aneurysmal changes.21 This study also showed that aminoguanidine, an iNOS inhibitor, reduced 
the incidence of induced CAs.21 In addition, another study demonstrated an upregulated gene 
profile related to reactive oxygen species, MMPs, growth factors, apoptosis, chemokines, adhesion 
molecules and complement in experimentally induced CAs.22  (Figure 1) Hasan et al. studied ten 
human CAs and introduced the concept of a macrophage subtype imbalance (M1: pro-
inflammatory; M2: anti-inflammatory) in ruptured versus unruptured aneurysms.23 Specifically, 
they showed that M1 and M2 were equally distributed within the aneurysm wall of unruptured 
aneurysms; in contrast, M1 pro-inflammatory macrophages were the predominant type of 
macrophages in ruptured aneurysms.23    
 
II) Genetics 
 The genetic predisposition to develop CAs and SAH has been well-established. There is 
an almost 2-fold and 4-fold or more increase in the incidence of CAs in patients with one and two 
affected first degree relatives, respectively, when compared to the general population.24,25 Familial 
CAs are more commonly multiple and found in the middle cerebral artery, may rupture at a 
younger age and may be larger than sporadic CAs.26–29 Genome-wide linkage studies have 
identified a number of susceptibility loci that may contain genes implicated in familial CAs.30 For 
example, 1p34.3-p36.13, 19q13.3, Xp22 and 7q11 were found to have a strong association with 
familial CAs.30–32 The 7q11 region contains the collagen type 1A2 gene and is adjacent to the 
elastin gene, both of which contribute to the structural integrity of the arterial walls.33–35 A 
systematic literature review showed that the 9p21/CDKN2, a loci which is implicated in vessel 
wall remodeling, had the strongest association with aneurysm rupture (Odds ratio: 1.42; p=0.01).36 
Another large scale genome-wide association study with approximately 2,000 patients with CAs 
and 8,000 controls reported single nucleotide polymorphisms in the 2q33.1, 8q11.23 and 9p21.3 
loci, which are thought to be associated with sporadic and familial CAs.37 Candidate genes that 
have been studied are MMPs, angiotensin-converting enzyme, phospholipase C, NOS, 
transforming growth factor-beta receptor among others. However, the outcomes of genetic linkage 
studies are inconsistent in the literature.33 Even though a large number of studies have implicated 
the effect of genetics on the development of CAs, it is more likely that CAs are the result of a 
multifactorial process where both genetics and environmental factors play a role. 
 On the other hand, several hereditary diseases with an established genetic profile are known 
to be associated with an increased risk of CA formation and rupture. The most common is 
autosomal dominant polycystic kidney disease (ADPKD), which has a mutation in the PKD1 and 
PKD2 genes. The prevalence of CAs in ADPKD is estimated within the range of 10-13% and up 
to 25% in those with a positive family history of CA or SAH.38 Other hereditary syndromes 
associated with CAs are fibromuscular dysplasia and Ehlers-Danlos type IV.24 
 
III) Risk Factors 
 Several modifiable and non-modifiable factors have been proposed to affect the risk of 
aneurysm formation, growth and rupture. The most studied and well-established modifiable factors 
are cigarette smoking and hypertension. Smoking and hypertension were independent risk factors 
for CA formation with an OR of 3.0 and 2.9, respectively.39 The same study highlighted that the 
combined risk of individuals who smoke and are hypertensive increases synergistically to a 
statistically significant OR of 8.3.39 Smoking and hypertension are both known to increase 
oxidative stress.  Oxidative stress acts as the initial hemodynamic insult causing endothelial injury 
and subsequent  inflammation, ultimately resulting in aneurysm formation.5 Smoking increases the 
production of reactive oxygen species through NADPH oxidase activation.40 In contrast, there is 
currently no strong evidence pointing towards a direct unidirectional link between hypertension, 
free radical generation and aneurysm formation. There is inconsistent evidence regarding the 
effect of alcohol consumption and formation of CAs; in comparison, heavy alcohol consumption 
has been shown to increase the risk of SAH.5,41 Atherosclerosis is also consistently present in 
saccular CAs; however, whether atherosclerosis can cause CAs is still unknown.42,43 
 As discussed above, family history of CAs and SAH is one of the non-modifiable risk 
factors which might be associated with specific genetic loci. Interestingly, the number of first-
degree relatives with SAH affects the risk of SAH for an individual. Bor et al. evaluated 
approximately 135,000 patients and showed that individuals with 1 affected and 2 affected 
relatives had an OR of 2.15 and 51, respectively, for an increased risk of SAH.44 Female gender 
and older age were also considered non-modifiable risk factors for CAs in a meta-analysis of 
95,000 patients.45 In addition, female patients had a three-fold increase in the risk of aneurysmal 
rupture compared to male patients.46 
 Hereditary syndromes are also non-modifiable risk factors. ADPKD-associated CAs are 
commonly found in the MCA and tend to have a small diameter (mean 4.4 mm).47,48 CAs in the 
ADPKD population occur in approximately 10-13% whereas in the general population the 
incidence ranges from 3-5%.38,49 However, a 20-year follow-up study and a systematic literature 
review suggested that the risk of growth or rupture in ADPKD patients is not higher when 
compared to the general population.47,50 These results, however, should be interpreted with caution 
as ADPKD patients usually receive more aggressive treatment after diagnosis. Ehlers-Danlos type 
IV is another hereditary syndrome with an associated increased risk of CAs; importantly, catheter 
angiography may be higher risk for these patients due to fragility of the arterial walls.51 Moreover, 
sickle cell anemia is considered a non-modifiable risk factor for CAs. Patients with sickle cell 
anemia might present with multiple aneurysms, including aneurysms in the posterior circulation. 
The presumed mechanism is endothelial injury due to the sickle cells.52,53 In addition, Loeys-Dietz 
syndrome is thought to be associated with a high risk of CA formation, with an estimated 
prevalence of CAs ranging from 10-28%;however, data is limited.54,55 A study of 376 hereditary 
hemorrhagic telangiectasia (HHT) patients reported that only 2.1% of patients harbored CAs.56 
Nevertheless, this study found that 12.8% of patients had arteriovenous malformations.56 Whether 
Marfan disease, neurofibromatosis, multiple endocrine neoplasia type I and acromegaly are 
associated with an increased risk to harbor CAs is still controversial.24,57–60  
 
Physics of CAs 
I) Geometry 
 A variety of geometrical factors have been utilized with the goal to determine CAs prone 
to rupture. One of the simplest factors that has been historically used is the maximal aneurysm 
size. Several suggestions have been made in the past with regards to maximal CA size. The critical 
threshold above which there is an increased risk of rupture varied between 5-10mm. Even though 
there is evidence that maximal size and CA rupture are correlated,61,62 data from studies comparing 
the diameter of ruptured vs unruptured CAs are inconclusive.63–65 A systematic literature review 
suggested that the mean difference of the diameter between ruptured and unruptured aneurysms 
was only 1.5mm.66 Importantly, data from a number of studies showed that 70-85% of the 
unruptured aneurysms had a maximal diameter of less than 10mm which further questions the 
applicability and sensitivity of this factor.67–69 
 Aspect ratio, defined as aneurysm height divided by aneurysm neck is considered a useful 
geometrical parameter that can be used for risk stratification. Reports from several studies have 
suggested that ruptured aneurysms most commonly have an average aspect ratio of 2.4 whereas 
unruptured aneurysms have an average aspect ratio of 1.6 or lower.66,70–72 A study of 129 patients 
with ruptured and 72 patients with unruptured CAs reported that approximately 80% of the 
ruptured aneurysms had an aspect ratio greater than 1.6, whereas almost 90% of the unruptured 
had aspect ratio less than 1.6.73 Nevertheless, there is no consensus with regards to an optimal 
aspect ratio threshold value that could be used in routine clinical practice. Future studies with 
larger patient samples and prospective design would be more likely to provide accurate thresholds 
with the potential to predict rupture. 
 Size ratio, is the aneurysm-to-parent vessel size ratio and has been shown to be a promising 
geometric factor that can help predict aneurysm instability and risk of rupture.74 Results from a 
prospective study underscored that size ratio was the only statistically significant predictor of 
aneurysm rupture (OR: 2.12; 95% CI: 1.09-4.13) and this was validated by larger studies.75,76 A 
virtual experimental study also reported that higher size ratio is associated with flow patterns 
typical for ruptured CAs, independent of aneurysm type and size.77  It has been also suggested 
that size ratio might be a more efficient predictor for rupture of small aneurysms <5mm.76 
 The area ratio defined as the ratio of the area of the aneurysm to the parent artery in the 
neck plane and may be a potential predictor of CA rupture. In a multicenter study of 2,674 CAs in 
Chinese population, area ratio ≥1.5 (adjusted OR, 4.089; 95% CI, 1.247–13.406), and irregular 
wall (adjusted OR, 10.443; 95% CI 3.394 –32.135) were significant predictive factors for 
aneurysm rupture after adjustment for aneurysm size.78 Of note, additional morphological 
parameters have been used with various applicability.79 In this era of technological advancements 
and development of novel imaging software, more sophisticated combinations of geometrical 
variables are emerging. This could lead to the development of an imaging-based predictive test 
which utilizes the morphological characteristics of an individual aneurysm and computes the 
adjusted risk of rupture with an acceptable area under the curve. 
 
II) Flow Patterns 
 CA flow has been investigated by clinical and experimental studies in animals and in vitro. 
The aneurysmal flow patterns are based on the geometrical indices of the CA-parent vessel 
complex and the volumetric flow characteristics in the afferent and efferent arteries. Different 
intra-aneurysmal flow patterns have been described in sidewall CAs, bifurcation aneurysms with 
symmetric or asymmetrical outflow and asymmetric bifurcation aneurysms.80 The typical flow 
pattern of a sidewall CA is characterized by flow that impinges on the distal CA neck, enters the 
aneurysm, travels along the wall and exits the CA at the proximal neck.66,81 This intra-aneurysmal 
flow pattern is also associated with reduced flow velocity in the center in theoretical models and 
human imaging studies.82,83 Geometric indices that impact flow patterns in bifurcation CAs are the 
bifurcation angle, branch diameters and flow dynamics in these branches.80 Flow in bifurcation 
CAs usually enters the side of the neck  which is closer to the larger branch, creates a vortex in the 
aneurysmal sac and exits into the daughter branch closest to the exit.84,85 Of note, higher aspect 
ratios affect the flow by creating a much slower circulation near the dome and reduce the flow 
penetrance in the aneurysm.85 Another important consideration when studying the flow patterns 
and flow dynamics of CAs is the cardiac cycle.86 For example, pulsatile flow during systole can 
drive blood flow from the parent vessel into the aneurysm, contributing to vortex formation, while 
the flow can either exit the aneurysm or redistribute into stagnation zones or vortical regions during 
diastole.86,87 There is also a temporal component in the flow patterns of the parent vessel at the 
aneurysm neck due to the cardiac cycle. More specifically, portions of the aneurysmal vortex or 
secondary flow structures (e.g. recirculation zones, helical flow patterns) may be generated at this 
location.88,89 However, individual aneurysms generally develop unique flow patterns which are 
affected by a number of geometrical indices, flow dynamics in the parent vessel and anatomy of 
the parent vessel-aneurysm complex. 
 
III) Flow Dynamics and Wall Shear Stress (WSS)  
 A detailed and accurate hemodynamic description of a CA would require the evaluation of 
blood velocities within the flow pattern, density and viscosity as well as the geometry and 
mechanical properties of the arterial wall. This would allow the description of WSS distribution in 
the parent artery and CA flow. WSS is defined as the force per unit area which is exerted by a solid 
boundary (i.e. arterial wall) on a fluid in motion (i.e. blood) and vice-versa, in a direction on the 
local tangent plane. The impact of WSS on cerebral arterial walls has been a subject of recent 
study. WSS has been found to affect endothelial homeostasis and induce aneurysm formation and 
atherosclerotic lesions.90–92 Meng et al. suggested that the combination of high WSS and high WSS 
gradient increases the risk for aneurysm formation at arterial bifurcations.92  However, there is 
conflicting evidence with regards to the mechanism through which WSS facilitates CA growth and 
rupture.93–96 Shojima et al. studied 20 middle cerebral artery aneurysms and proposed that a high 
WSS may contribute to the initial phase of hemodynamic stress, but that a low WSS may promote 
aneurysmal growth and increase the risk of rupture due to degenerative wall changes.94 Similarly, 
Miura et al. compared the morphologic and hemodynamic parameters between ruptured and 
unruptured CAs and showed that low WSS was the only independent predictor of aneurysm 
rupture in multivariate analyses.95 In contrast, a study of 210 patient-specific CA geometries 
performed 1,050 image-based computational flow dynamics simulations and reported that elevated 
maximum WSS is associated with a positive history of CA rupture.93 Interestingly, the authors  
also highlighted that low WSS levels did not show any association with rupture.93 However, it 
should be noted that growing CAs tend to have complex flow patterns which induce variable WSS 
distributions along the CA wall.97 There is also evidence that low WSS with high oscillations may 
induce focal CA growth (i.e. bleb or blister) while high WSS may be associated with global 
enlargement of the CA.98  Future studies are needed to better characterize the effect of WSS on 
aneurysm formation, growth and rupture. 
 The mechanism through which WSS exerts its effects on the vascular wall and endothelium 
has been investigated by a number of studies. WSS is known to trigger several kinase pathways 
which lead to the activation of multiple transcription factors and result in the translation of 
vasoactivators, monocyte chemoattractants and endothelial growth factor genes that dysregulate 
vascular homeostasis and function.90 A study of elastase-induced CAs in rabbits demonstrated that  
low WSS was associated with upregulation of MMPs or pro-MMPs and downregulation of their 
inhibitors, as compared to the control group.99 Importantly, Wang et al. suggested that high WSS 
decreased endothelial NOS expression and increased inflammatory markers in the CA as compared 
to adjacent arterial segments and controls.100 In conclusion, despite the complex interactions of 
hemodynamics with CA formation, growth and rupture, it is likely that both increased and 
decreased WSS contribute to the initial hemodynamic stress insult to the cerebrovascular tree, 
albeit with different mechanisms.101 
 
Imaging Techniques and Risk Stratification 
Investigating the pathophysiological mechanisms implicated in CA formation and growth 
is as important as developing novel tools that will provide new insights in the risk stratification of 
CAs. Advances in imaging techniques that utilize the established knowledge of  inflammatory 
pathways associated with CA formation are already showing promising results. The use of high 
resolution magnetic resonance imaging has been used for a variety of cerebrovascular diseases 
including CA evaluation.102 It has been hypothesized that aneurysmal wall enhancement may be a 
surrogate marker of wall inflammation. A meta-analysis by Texakalidis et al. showed that CAs 
with wall enhancement had statistically significant higher odds of being unstable (OR: 20; 95% 
CI: 6.4-62.1) with a sensitivity of 95% (90.4-97.8) and a negative predictive value of 96.2% (92.8-
98).103 Another imaging technique targeting inflammatory cells is Ferumoxytol-Enhanced MRI. 
Ferumoxytol is a nanoparticle that can be used as a contrast agent and marker of inflammation 
because it is cleared by macrophages.104 A number of studies has also suggested that Ferumoxytol-
Enhanced MRI may also help individualize risk stratification for rupture in CAs.105,106 Hasan et al 
showed that uptake of Ferumoxytol in the CA wall within the first 24 hours may predict aneurysm 
instability and rupture in the next six months.105  Future studies are anticipated to validate these 
results. 
In addition, risk stratification with the use of the Unruptured Intracranial Aneurysm 
Treatment Score (UIATS) or PHASES, based on easily available characteristics of the patient and 
the CA, may prove to be accurate and guide clinical decision making.107,108 
 
Conclusions 
 The pathophysiology of CAs has been extensively studied.  The inflammatory pathways 
and physics behind the formation, growth and rupture of CAs have been described by a number of 
experimental and clinical studies. The combination of current scientific knowledge has allowed 
for the development of novel imaging techniques with the potential to optimize risk stratification 
of aneurysms prone to rupture. Future studies are anticipated to expand our understanding of this 
disease and develop innovative treatments. 
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Figure Legends 
 
Figure 1.  Cerebral aneurysm (CA) formation and rupture. Aneurysm formation is initiated by 
hemodynamically triggered endothelial dysfunction. An inflammatory response implicating 
several cytokines and inflammatory mediators as well as macrophages, T cells, and mast cells 
ensues. Concurrently, smooth muscle cells (SMCs) undergo phenotypic modulation to a pro-
inflammatory phenotype. The inflammatory response in vessel wall leads to disruption of 
internal elastic lamina, extracellular matrix digestion, and aneurysm formation. Loss of mural 
cells and further inflammation and vessel wall degeneration ultimately lead to CA rupture. bFGF 
indicates basic fibroblast growth factor; COX2, cyclooxygenase-2; ECM, extracellular matrix; 
ICAM, intercellular adhesion molecule; IL, interleukin; MCP, monocyte chemoattractant 
protein; MMP, matrix metalloproteinase; NK, natural killer; NO, nitric oxide; PGD, 
prostaglandin D; PGE, prostaglandin E; ROS, reactive oxygen species; TGF, transforming 
growth factor; TLR, toll-like receptor; TNF, tumor necrosis factor; VCAM, vascular cell 
adhesion molecule; VEGF, vascular endothelial growth factor; and VSMC, vascular smooth 
muscle cell. (Copyright 2019 Wiley. Used with permission from Chalouhi N, Hoh BL, Hasan D. 
Review of cerebral aneurysm formation, growth, and rupture. Stroke. 2013;44(12):3613-3622. 
doi:10.1161/STROKEAHA.113.002390) 
